News Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Email Alerts

Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go

Advanced Search

Keywords

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• Aug 8, 2011

  Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011
• Aug 1, 2011

  Insmed Incorporated Announces Clinical Hold on ARIKACE® Phase 3 Clinical Trials
• Jul 26, 2011

  Insmed to Host 2011 Second Quarter Earnings Conference Call
• Jul 18, 2011

  Andrea Drucker Joins Insmed as General Counsel
• Jun 28, 2011

  Insmed Announces its Addition to the Russell 3000® Index
• Jun 10, 2011

  Insmed's ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections
• May 10, 2011

  Insmed Announces First Quarter 2011 Financial Results

  Insmed Announces First Quarter 2011 Financial Results
• Apr 26, 2011

  Insmed to Host 2011 First Quarter Earnings Conference Call

  Insmed to Host 2011 First Quarter Earnings Conference Call
• Mar 21, 2011

  Insmed Regains NASDAQ Compliance
• Mar 21, 2011

  Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication

Show 5102550100 per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download